A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells

Overview

Journal Sci Rep

Specialty Science

Date 2016 Oct 18

PMID 27748367

Citations 29

Authors

Elizabeth Thomas

Vidya Gopalakrishnan

Mahesh Hegde

Sujeet Kumar

Subhas S Karki

Sathees C Raghavan

Bibha Choudhary

Affiliations

Soon will be listed here.

Abstract

Resveratrol is one of the most widely studied bioactive plant polyphenols which possesses anticancer properties. Previously we have reported synthesis, characterization and identification of a novel resveratrol analog, SS28. In the present study, we show that SS28 induced cytotoxicity in several cancer cell lines ex vivo with an IC value of 3-5 μM. Mechanistic evaluation of effect of SS28 in non-small cell lung cancer cell line (A549) and T-cell leukemic cell line (CEM) showed that it inhibited Tubulin polymerization during cell division to cause cell cycle arrest at G2/M phase of the cell cycle at 12-18 h time period. Immunofluorescence studies confirmed the mitotic arrest upon treatment with SS28. Besides, we show that SS28 binds to Tubulin with a dissociation constant of 0.414 ± 0.11 μM. Further, SS28 treatment resulted in loss of mitochondrial membrane potential, activation of Caspase 9 and Caspase 3, leading to PARP-1 cleavage and finally cell death via intrinsic pathway of apoptosis. Importantly, treatment with SS28 resulted in regression of tumor in mice. Hence, our study reveals the antiproliferative activity of SS28 by disrupting microtubule dynamics by binding to its cellular target Tubulin and its potential to be developed as an anticancer molecule.

Citing Articles

VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis.

Waddell S, Zhao G, Liu Z, Chen H, Zhang W, Wang Y J Pharmacol Exp Ther. 2025; 392(1):100006.

PMID: 39893008 PMC: 11808928. DOI: 10.1124/jpet.124.002298.

A Novel Pyrazole Exhibits Potent Anticancer Cytotoxicity via Apoptosis, Cell Cycle Arrest, and the Inhibition of Tubulin Polymerization in Triple-Negative Breast Cancer Cells.

Borrego E, Guerena C, Schiaffino Bustamante A, Gutierrez D, Valenzuela C, Betancourt A Cells. 2024; 13(14.

PMID: 39056806 PMC: 11274517. DOI: 10.3390/cells13141225.

Unravelling the Intricate Roles of FAM111A and FAM111B: From Protease-Mediated Cellular Processes to Disease Implications.

Naicker D, Rhoda C, Sunda F, Arowolo A Int J Mol Sci. 2024; 25(5).

PMID: 38474092 PMC: 10931937. DOI: 10.3390/ijms25052845.

Resveratrol-loaded invasome gel: A promising nanoformulation for treatment of skin cancer.

Samir B, El-Kamel A, Zahran N, Heikal L Drug Deliv Transl Res. 2024; 14(12):3354-3370.

PMID: 38361173 PMC: 11499415. DOI: 10.1007/s13346-024-01534-9.

Design and Synthesis of Ketenimine Sulfonamide Conjugates through Multicomponent Reactions; A Combined Cytotoxic Analysis and Computational Exploration.

Prabhu D, Ray U, Rajeev A, Joy R, George A, George J ACS Omega. 2023; 8(41):38619-38631.

PMID: 37867708 PMC: 10586297. DOI: 10.1021/acsomega.3c05816.

References

Milas L, Hunter N, Kurdoglu B, Mason K, Meyn R, Stephens L . Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol. 1995; 35(4):297-303. DOI: 10.1007/BF00689448. View

Surh Y, Hurh Y, Kang J, Lee E, Kong G, Lee S . Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 1999; 140(1-2):1-10. DOI: 10.1016/s0304-3835(99)00039-7. View

Noaman E, Badr El-Din N, Bibars M, Abou Mossallam A, Ghoneum M . Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma. Cancer Lett. 2008; 268(2):348-59. DOI: 10.1016/j.canlet.2008.04.012. View

Srivastava M, Hegde M, Chiruvella K, Koroth J, Bhattacharya S, Choudhary B . Sapodilla plum (Achras sapota) induces apoptosis in cancer cell lines and inhibits tumor progression in mice. Sci Rep. 2014; 4:6147. PMC: 4139949. DOI: 10.1038/srep06147. View

Jeung H, Che X, Haraguchi M, Furukawa T, Zheng C, Sumizawa T . Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents. Biochem Pharmacol. 2005; 70(1):13-21. DOI: 10.1016/j.bcp.2005.04.017. View

Sherline P, Leung J, KIPNIS D . Binding of colchicine to purified microtubule protein. J Biol Chem. 1975; 250(14):5481-6. View

Gireesh K, Rashid A, Chakraborti S, Panda D, Manna T . CIL-102 binds to tubulin at colchicine binding site and triggers apoptosis in MCF-7 cells by inducing monopolar and multinucleated cells. Biochem Pharmacol. 2012; 84(5):633-45. DOI: 10.1016/j.bcp.2012.06.008. View

Doree M, Galas S . The cyclin-dependent protein kinases and the control of cell division. FASEB J. 1994; 8(14):1114-21. DOI: 10.1096/fasebj.8.14.7958616. View

Wilson L . Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin. Biochemistry. 1970; 9(25):4999-5007. DOI: 10.1021/bi00827a026. View

10.

Choy H . Taxanes in combined modality therapy for solid tumors. Crit Rev Oncol Hematol. 2001; 37(3):237-47. DOI: 10.1016/s1040-8428(00)00112-8. View

11.

Sharma S, Panjamurthy K, Choudhary B, Srivastava M, Shahabuddin M, Giri R . A novel DNA intercalator, 8-methoxy pyrimido[4',5':4,5]thieno (2,3-b)quinoline-4(3H)-one induces apoptosis in cancer cells, inhibits the tumor progression and enhances lifespan in mice with tumor. Mol Carcinog. 2012; 52(6):413-25. DOI: 10.1002/mc.21867. View

12.

Kruczynski A, Hill B . Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties. Crit Rev Oncol Hematol. 2001; 40(2):159-73. DOI: 10.1016/s1040-8428(01)00183-4. View

13.

Jordan M, Thrower D, Wilson L . Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 1991; 51(8):2212-22. View

14.

Thomas E, Gopalakrishnan V, Somasagara R, Choudhary B, Raghavan S . Extract of Vernonia condensata, Inhibits Tumor Progression and Improves Survival of Tumor-allograft Bearing Mouse. Sci Rep. 2016; 6:23255. PMC: 4806354. DOI: 10.1038/srep23255. View

15.

Morris G, Huey R, Lindstrom W, Sanner M, Belew R, Goodsell D . AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009; 30(16):2785-91. PMC: 2760638. DOI: 10.1002/jcc.21256. View

16.

Signorelli P, Ghidoni R . Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem. 2005; 16(8):449-66. DOI: 10.1016/j.jnutbio.2005.01.017. View

17.

Nabha S, Mohammad R, Dandashi M, Aboukameel A, Pettit G, Al-Katib A . Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage. Clin Cancer Res. 2002; 8(8):2735-41. View

18.

Bhattacharyya B, Wolff J . Promotion of fluorescence upon binding of colchicine to tubulin. Proc Natl Acad Sci U S A. 1974; 71(7):2627-31. PMC: 388519. DOI: 10.1073/pnas.71.7.2627. View

19.

Srivastava M, Nambiar M, Sharma S, Karki S, Goldsmith G, Hegde M . An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell. 2012; 151(7):1474-87. DOI: 10.1016/j.cell.2012.11.054. View

20.

Chiruvella K, Kari V, Choudhary B, Nambiar M, Ghanta R, Raghavan S . Methyl angolensate, a natural tetranortriterpenoid induces intrinsic apoptotic pathway in leukemic cells. FEBS Lett. 2008; 582(29):4066-76. DOI: 10.1016/j.febslet.2008.11.001. View